A 3D Model for Human Melanocortin 4 Receptor Refined with Molecular Dynamics Simulation
Authors
Abstract
Despite a quite short early history, computational drug design and discovery methods can now be efficient in reducing costs and speeding up drug developing procedure. Melanocortin-4 receptor (MC4R) is a G protein-coupled receptor implicated in the regulation of body weight. Despite its clinical reputation, there is a lack of in-depth knowledge about structure and behavior of MC4R in lipid bilayer due to the absence of a crystal structure. In this context, a computational investigation was presented to study the Melnocortin 4 receptor (MC4R) receptor integrating homology modeling (HM) and molecular dynamics (MD) simulations. A homology-based model of the MC4R receptor was produced. The resulting homology model of the receptor was then used for molecular dynamics simulation studies in explicit POPC. The receptor structure that ensued was refined and the final native conformation was obtained.
Highlights
Copyright
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Three New Scorpion Chloride Channel Toxins as Potential Anti-Cancer Drugs: Computational Prediction of The Interactions With Hmmp-2 by Docking and Steered Molecular Dynamics Simulations
Baradaran M, Jalali A, Naderi Soorki M, Jokar M, Galehdari H. Three New Scorpion Chloride Channel Toxins as Potential Anti-Cancer Drugs: Computational Prediction of The Interactions With Hmmp-2 by Docking and Steered Molecular Dynamics Simulations. Iran J Pharm Res. 2019;18(2):e126209. doi: https://doi.org/10.22037/ijpr.2019.1100659
In Silico Analysis of Ivermectin Interaction with NF-κB, MAPK10, and MAPK14 Inflammatory Agents as a Candidate for Treatment of COVID-19 Disease
Farasat A, Hooshmand A, Zolghadr L, Gheibi N. In Silico Analysis of Ivermectin Interaction with NF-κB, MAPK10, and MAPK14 Inflammatory Agents as a Candidate for Treatment of COVID-19 Disease. J Inflamm Dis. 2023;27(2):e150908. doi: https://doi.org/10.69107/jid-150908
Theoretical Investigation on Atomic Interaction of T-Anethole Drug – Hormone Receptors: Molecular Dynamics Approach
Boushehri H, Movahedi M, Bahreini M. Theoretical Investigation on Atomic Interaction of T-Anethole Drug – Hormone Receptors: Molecular Dynamics Approach. J Rep Pharm Sci. 2025;13(1):e157309. doi: https://doi.org/10.5812/jrps-157309
Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking
Jafari F, Nowroozi A, Shahlaei M. Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking. Iran J Pharm Res. 2018;17(4):e124882. doi: https://doi.org/10.22037/ijpr.2018.2288
Elucidating the Inhibitory Potential of Statins Against Oncogenic c-Met Tyrosine Kinase Through Computational and Cell-based Studies
Ahmad Alizadeh E, Karami L, Ghasemi F, Shadboorestan A, Torabi MR, et al. Elucidating the Inhibitory Potential of Statins Against Oncogenic c-Met Tyrosine Kinase Through Computational and Cell-based Studies. Iran J Pharm Res. 2025;24(1):e158845. doi: https://doi.org/10.5812/ijpr-158845
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 5
Last Update: 1 week ago
- Scopus by Title (Ref): 5
Last Update: 1 week ago
- CrossRef: 0
Last Update: 9 hours ago
- OpenAlex: 0
Last Update: 11 hours ago
- OpenCitations: 0
Last Update: 5 days ago